A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Phase of Trial: Phase III
Latest Information Update: 06 Nov 2018
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Acronyms THWART-1
- Sponsors Aclaris Therapeutics
- 06 Nov 2018 According to an Aclaris Therapeutics media release,topline data is expected in second half of 2019.
- 28 Sep 2018 New trial record
- 24 Sep 2018 According to an Aclaris Therapeutics media release, First Patient Dosed in this study.